Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes

European Journal of Immunology

Volumn 28, Issue 9, 1998, Pages 2791-2800

  Frazer, Ian H ^a   Fernando, Germain J P ^a   Fowler, Nina ^a   Leggatt, Graham R ^a   Lambert, Paul F ^b   Liem, Amy ^b   Malcolm, Karen ^a   Tindle, Robert W ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Autoimmunity; Repertoire development; Skin; T lymphocyte; Thymus

Indexed keywords

VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITHELIUM; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; KERATINOCYTE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; THYMUS; TRANSGENE; TRANSGENIC MOUSE; VIRUS IMMUNITY; WART VIRUS;

ANIMALS; ANTIGENS, VIRAL; EPITHELIUM; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE TOLERANCE; KERATINOCYTES; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; THYMUS GLAND;

EID: 0031719384     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199809)28:09<2791::AID-IMMU2791>3.0.CO;2-B     Document Type: Article

References (41)

1. Kappler, J. W., Boehm, N. and Marrack, P., T cell tolerance by clonal elimination in the thymus. Cell 1997. 49: 273-280.
2. Brocker, T., Riedinger, M. and Karjalainen, K., Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 1997. 185: 541-550.
3. b expressed under the control of the rat insulin promoter. Transgenics 1994. 1: 349-355.
4. + T cells is transient and depends on avidity. J. Immunol. 1995. 155: 2339-2349.
5. Ferber, I., Schönrich, G., Schenkel, J., Mellor, A. L., Hämmerling, G. J. and Arnold, B., Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 1994. 263: 674-676.
6. b in the liver. Eur. J. Immunol. 1995. 25: 1932-1942.
7. Schönrich, G., Momburg, F., Malissen, M., Schmitt-Verhulst, A.-M., Malissen, B. and Hämmerling, G. J., Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int. Immunol. 1992. 4: 581-590.
8. Ohashi, P. S., Oehen, S., Buerki, K., Pircher, H., Ohashi, C. T., Odermatt, B., Malissen, B., Zinkernagel, R. M. and Hengartner, H., Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991. 65: 305-317.
9. Miller, J. F. A. P. and Basten, A., Mechanisms of tolerance to self. Curr. Opin. Immunol. 1996. 8: 815-821.
10. Bevan, M. J., In thymic selection, peptide diversity gives and takes away. Immunity 1997. 7: 175-178.
11. Akkaraju, S., Ho, W. Y., Leong, D., Canaan, K., Davis, M. M. and Goodnow, C. C., A range of CD4 T cell tolerance: Partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 1997. 7: 255-271.
12. Laufer, T. M., DeKoning, J., Markowitz, J. S., Lo, D. and Glimcher, L. H., Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 1996. 383: 81-85.
13. Sant'Angelo, D. B., Waterbury, P. G., Cohen, B. E., Martin, W. D., Van Kaer, L., Hayday, A. C. and Janeway, C. A. Jr., The imprint of intrathymic self-peptides on the mature T cell receptor repertoire. Immunity 1997. 7: 517-524.
14. Griep, A. E., Herber, R., Jeon, S., Lohse, J. K., Dubielzig, R. R. and Lambert, P. F., Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J. Virol. 1993. 67: 1373-1384.
15. Frazer, I. H., Leippe, D. M., Dunn, L. A., Liem, A., Tindle, R. W., Fernando, G. J., Phelps, W. C. and Lambert, P. F., Immunological responses in human papillo-mavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Cancer Res. 1995. 55: 2635-2639.
16. Herber, R., Liem, A., Pilot, H. and Lambert, P. F., Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J. Virol. 1996. 70: 1873-1881.
17. Lambert, P. F., Pan, H., Pitot, H., Liem, A., Jackson, M. and Griep, A. E., Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. USA 1993. 90: 5583-5587.
18. Herd, K., Fernando, G. J. P., Dunn, L. A., Frazer, I. H., Lambert, P. and Tindle, R. W., E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B-or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein. Virology 1997. 231: 155-165.
19. Tindle, R. W., Fernando, G. J., Sterling, J. C. and Frazer, I. H., A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc. Natl. Acad. Sci. USA 1991. 88: 5887-5891.
20. Tindle, R. W., Smith, J. A., Geysen, H. M., Selvey, L. A. and Frazer, I. H., Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. J. Gen. Virol. 1990. 71: 1347-1354.
21. Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., De Jongh, B. M., Wouter Drijfhout, J., Ter Schegget, J., Melief, C. J. M. and Kast, W. M., Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J. Immunol. 1993. 23: 2242-2249.
22. Fernando, G. J., Stewart, T., Tindle, R. W. and Frazer, I. H., Induction of tumor antigen specific CTL mediated tumour protection, is not altered by prior induction of a TH2 type response specific for the same tumour antigen. J. Immunol. 1998, in press.
23. Bal, V., McIndoe, A., Denton, G., Hudson, D., Lombardi, G., Lamb, J. and Lechler, R., Antigen presentation by keratinocytes induces tolerance in human T cells. Eur. J. Immunol. 1990. 20: 1893-1897.
24. Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., Pritchard-Briscoe, H., Wotherspoon, J. S., Loblay, R. H., Raphael, K., Trent, R. J. and Basten, A., Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988. 334: 676-682.
25. + T cells. J. Exp. Med. 1997. 186: 239-245.
26. Doan, T., Chambers, M., Street, M., Fernando, G. J. P., Herd, K., Lambert, P. and Tindle, R. W., Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance to E7-encoded cytotoxic T-lymphocytes (CTL) epitopes. Virology 1998. 244: 352-364.
27. Dunn, L. A., Evander, M., Tindle, R. W., Bulloch, A. L., De Kluyver, R. L., Fernando, G. J., Lambert, P. F. and Frazer, I. H., Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal. Virology 1997. 235: 94-103.
28. Chambers, M. A., Wei, Z., Coleman, N., Nash, A. A. and Stanley, M. A., "Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness. Eur. J. Immunol. 1994. 24: 738-745.
29. Melero, I., Singhal, M. C., McGowan, P., Haugen, H. S., Blake, J., Hellstrom, K. E., Yang, G., Clegg, C. H. and Chen, L., Immunological ignorance of an E7 encoded cytotoxic T lymphocyte in transgenic mice expressing the E7 and E6 oncogenes of human papillo-mavirus type. 16. J. Virol. 1997. 71: 3998-4004.
30. Fernando, G. J. P., Stewart, T., Tindle, R. W. and Frazer, I. H., Vaccine induced Th1 type responses are dominant over Th2 type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term. Scand. J. Immunol. 1998. 47: 459-465.
31. + T cell help. J. Exp. Med. 1997. 186: 65-70.
32. Zinkernagel, R. M., Pircher, H. P., Ohashi, P., Oehen, S., Odermatt, B., Mak, T., Arnheiter, H., Burki, K. and Hengartner, H., T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease. Immunol. Rev. 1991. 122: 133-171.
33. Reynolds, P., Gordon, T. P., Purcell, A. W., Jackson, D. C. and McCluskey, J., Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self-antigen La (SS-B) permits induction of systemic autoimmunity in normal mice. J. Exp. Med 1996. 184: 1857-1870.
34. Topfer, F., Gordon, T. and McCluskey, J., Intra-and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc. Natl. Acad. Sci. USA 1995. 92: 875-879.
35. + antigen-specific T cells after in vivo exposure to male antigen. J. Immunol. 1992. 148: 3740-3745.
36. Aida, Y. and Pabst, M. J., Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods 1990. 132: 191-195.
37. Fernando, G. J., Tindle, R. W. and Frazer, I. H., T-helper epitopes of the E7 transforming protein of cervical cancer associated human papillomavirus type 18 (HPV18). Virus Res. 1995. 36: 1-13.
38. Seedorf, K., Oltersdorf, T., Krammer, G. and Rowenkamp, W., Identification of early proteins of the human papillomaviruses type 16 (HPV16) and type 18 (HPV18) in cervical carcinoma cells. EMBO J. 1987. 6: 139-144.
39. Crook, T., Storey, A., Almond, N., Osborn, K. and Crawford, L., Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells. Proc. Natl. Acad. Sci. USA 1988. 85: 8820-8824.
40. Tindle, R. W., Croft, S., Herd, K., Malcolm, K., Geczy, A. F., Stewart, T. and Fernando, G. J. P., A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomarvirus type 16 elicits specific Th1-and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clin. Exp. Immunol. 1995. 101: 265-271.
41. Fernando, G. J., Stenzel, D. J., Tindle, R. W., Merza, M. S., Morein, B. and Frazer, I. H., Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production. Vaccine 1995. 13: 1460-1467.